LivingGLP1
Study S000895

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Registration

Registration
NCT05482789
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
RECRUITING
Enrollment
13
Start
2023-04-12
Primary completion
2025-12-31
Lead sponsor
Maisa N. Feghali, MD
Conditions
Gestational Diabetes
Interventions
DRUG:Exenatide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Area Under the Plasma Concentration Versus Time Curve (AUC) of glucose [Baseline and 1 week later]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.